Amneal Pharmaceuticals, Inc. (AMRX) Retained Earnings (Accumulated Deficit) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Amneal Pharmaceuticals, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2017 to 2024.
  • Amneal Pharmaceuticals, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$582 M, a 40.8% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$582 M -$169 M -40.8% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$490 M -$84 M -20.7% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 -$392 M +$10.3 M +2.57% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$401 M -$2.05 M -0.51% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$413 M -$135 M -48.4% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$406 M -$130 M -47.1% Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$402 M -$132 M -48.9% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$399 M -$134 M -50.3% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$278 M +$1.76 M +0.63% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 -$276 M +$10.6 M +3.7% Dec 31, 2021 10-K 2023-03-03
Q3 2021 -$270 M +$14 M +4.92% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 -$266 M +$9.23 M +3.36% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$280 M -$17.3 M -6.58% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 -$287 M +$91.1 M +24.1% Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$284 M +$62 M +17.9% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 -$275 M -$194 M -240% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 -$263 M -$199 M -312% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 -$378 M -$357 M -1706% Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$346 M -$334 M -2745% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 -$80.7 M -$61.6 M -323% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 -$63.8 M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$20.9 M +$362 M +94.5% Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$12.2 M Sep 30, 2018 10-Q 2018-11-07
Q2 2018 -$19.1 M Jun 30, 2018 10-Q 2018-08-09
Q4 2017 -$383 M Dec 31, 2017 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.